IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dcvc Opportunity Fund II GP, LLC

Q4 2024 Holdings

Filed 2025-02-14 | 2 holdings | $113.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rocket Lab USA, Inc.COM773122106$86.3M3,388,24976.4%
Recursion Pharmaceuticals, Inc.(RXRX)CL A75629V104$26.7M3,951,14123.6%